XanTec bioanalytics offers the following products and services:
- SPR sensorchips
- SPR instruments
- Slides for Protein and DNA microarray production
- Custom coating with biocompatible nanocoatings
- Assay development
Xceed Capital Ltd (Xceed) is an investment company based in Perth, Australia and is listed on the Australian Stock Exchange (ASX: XCD). Historically, Xceed has worked closely with CSIRO to successfully spin-off two companies.
XCellr8 is GLP-accredited contract laboratory which provides cell culture based in vitro testing for product safety and efficacy to cosmetics, personal care, healthcare and household chemical companies and their raw material suppliers.
XDx has applied microarray, real-time PCR (polymerase chain reaction) and bioinformatics technologies to develop a new way to monitor the immune system. The company's first commercial service, AlloMap molecular expression testing is a noninvasive, multi-g
We provide custom cell-based and immunotoxicology assays. We offer development services for Mixed Lymphocyte Reactions, Cytotoxicity Assays, Cell Proliferation Assays, Phagocytosis Assays, and more. We offer, GLP, CLIA, and non-GLP (RUO) formats.
XenoBiotic Laboratories, Inc. is a leading contract laboratory specializing in preclinical ADME, PK/TK, in vitro/vivo drug metabolism, human radiolabel studies, bioanalytical method development/validation and clinical sample analysis.accredited
Xenogenics Corporation, subsidiary of MultiCell Technologies, Inc., holds rights and patents to the development-stage SybiolR synthetic bio-liver. It is an excorporeal cellular therapy device, comparable to dialysis, designed to treat liver patients.
Xenometrix is a company specialized in the production, distribution and service of mutagenicity test systems, namely Ames II, Ames MPF 98/100, Ames MPF 1535, Ames MPF 1537, Ames MPF E.coli WP2 uvrA, Ames MPF E.coli WP2 pkM101
Xeno Medical has over 45 years experience in the field and has operated at the highest levels of international industry and academia. We have demonstrable results in business creation, adding value, technology transfer, market entry and due diligence.
Xenon is a privately owned, genomics-based drug discovery and development company engaged in identifying genes and other drug targets associated with human disease and developing pharmaceutical therapies based on these genetically-derived targets.
XenoPort Inc. is a privately held biopharmaceutical company focused on developing products which harness the body's intrinsic transport systems to improve the oral absorption, distribution, and pharmacokinetics of drugs.
Founded in 1996, Xenos Bioresources, Inc. (XBI) was organized with the objective of providing the biotechnology, biopharmaceutical, veterinary and nutraceutical industries with the best available products to meet their sourcing needs
Our primary focus is filtration, sample preparation and liquid chromatography for a wide range of environmental and pharmaceutical applications. In addition to a full line of optimized products, we work with clients to develop proprietary solutions for th
A consultation on xenotransplantation. Xenotransplantation is the use of live, non-human animal cells, tissues and organs in humans. Xenotransplants could potentially provide an alternative source of organs and tissues for patients in Canada.
Xeotron produces customizable, high density, long oligo microarrays. Researchers can now have complete control of the content of high quality gene expression studies without the high upfront costs and delays - any gene, any species, no minimum order.